Superinfections in the antibiotic era.
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001419:Bacteria / Q000302:isolation & purification; D002177:Candidiasis / Q000401:mortality; D003428:Cross Infection; D004754:Enterobacter / Q000302:isolation & purification; D005260:Female; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D007711:Klebsiella pneumoniae / Q000302:isolation & purification; D008297:Male; D008826:Microbial Sensitivity Tests; D009154:Mutation; D009175:Mycoplasma Infections / Q000188:drug therapy; D010118:Oxytetracycline / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000401:mortality; D013210:Staphylococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013297:Streptococcus pyogenes / Q000302:isolation & purification; D013307:Streptomycin / Q000627:therapeutic use; D013752:Tetracycline / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013752:Tetracycline; D010118:Oxytetracycline; D013307:Streptomycin